Why are investors looking for Cost Plus Drug Company IPO?

Be the First to Comment Read

Why are investors looking for Cost Plus Drug Company IPO?

Follow us on Google News:
 Why are investors looking for Cost Plus Drug Company IPO?
Image source: © Stavklem | Megapixl.com
Highlights:
  • The Cost Plus Drug Company is an online pharmacy and was launched to offer low-cost alternatives to high-cost generic drugs.
  • Mark Cuban Cost Plus Drug Company offers 100 life-saving generic drugs at a low cost.
  • Mark Cuban Cost Plus Drug Company provides cheaper drugs as it removes insurance plans and intermediaries.

Last month, Mark Cuban, an American entrepreneur and billionaire, took everyone by surprise when he launched the Mark Cuban Cost Plus Drug Company (MCCPDC).

The Cost Plus Drug Company is an online pharmacy and was launched to offer low-cost alternatives to high-cost generic drugs. For example, MCCPDC aims to offer imatinib for US$ 47 per month.

Imatinib is a type of cancer growth blocker and is generally available for US$ 120 or more with a common voucher, and it has a retail price of US$ 9,657 per month.

Also Read: Can you buy TRUTH Social stock?

Mark Cuban is a famous person, and he is the star of a popular TV show named Shark Tank. Additionally, he is the owner of the Dallas Mavericks basketball team.

Since the launch of the online pharmacy store, potential investors seem to be looking for Mark Cuban Cost Plus Drug Company IPO plans. On that note, let's find out more about the company.

Why are investors looking for Cost Plus Drug Company IPO plans?

According to a 2021 Gallup poll, around 18 million people in the United States can't afford at least one prescribed medicine due to a high cost. Meanwhile, one out of 10 people skipped doses of their prescribed medicines to reduce expenditure.

Mark Cuban Cost Plus Drug Company offers 100 life-saving generic drugs at a low cost. According to reports, some of the medicines provided by MCCPDC are ten times cheaper than those sold by other stores.

Cost Plus Drug Company IPO                                                                                            ©2022 Kalkine Media® 

As the healthcare sector draws an increased investors' attention after the breakout of the coronavirus pandemic, it seems that Cost Plus Drug Company is attracting potential investors due to this reason.

Also Read: What is PayMongo and why is it grabbing attention?

Also, investing in IPOs brings the prospect of getting higher returns at the time of public debut. However, investors don't always earn profit by investing in pre-IPO stocks.

Bottom line

It is uncertain if Cost Plus Drug IPO will happen. The company has not revealed any public debut plans.

Mark Cuban Cost Plus Drug Company provides cheaper drugs by removing insurance plans and intermediaries.

Disclaimer

Featured Articles

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK